 |
|
Tumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma
In Kook Jung, Sun Sook Kim, Dong Soo Suh, Ki Hyung Kim, Chang Hoon Lee, Man Soo Yoon
Obstet Gynecol Sci. 2014;57(4):266-273. Published online 2014 Jul 15 DOI: https://doi.org/10.5468/ogs.2014.57.4.266
|
|
Citations to this article as recorded by
 Exploring prognostic microbiota markers in patients with endometrial carcinoma: Intratumoral insights
Jie Liu, Yi Qu, Yang-Yang Li, Ya-Lan Xu, Yi-Fang Yan, Hao Qin
Heliyon.2024; 10(6): e27879. CrossRef Prognostic implications of tumor-infiltrating T cells in early-stage endometrial cancer
Marta Mendiola, Teijo Pellinen, Jorge L. Ramon-Patino, Alberto Berjon, Oscar Bruck, Victoria Heredia-Soto, Riku Turkki, Javier Escudero, Annabrita Hemmes, Luis E. Garcia de la Calle, Roberto Crespo, Alejandro Gallego, Alicia Hernandez, Jaime Feliu, Andres
Modern Pathology.2022; 35(2): 256. CrossRef Immune checkpoint proteins (PD-L1 and CTLA-4) in endometrial carcinoma: prognostic role and correlation with CD4+/CD8+ tumor infiltrating lymphocytes (TILs) ratio
Rana Khalifa, Nawal Elsese, Karima El-Desouky, Hassan Shaair, Duaa Helal
Journal of Immunoassay and Immunochemistry.2022; 43(2): 192. CrossRef Endometrial Cancer Suppresses CD8+ T Cell-Mediated Cytotoxicity in Postmenopausal Women
Mickey V. Patel, Zheng Shen, Marta Rodriguez-Garcia, Edward J. Usherwood, Laura J. Tafe, Charles R. Wira
Frontiers in Immunology.2021;[Epub] CrossRef Higher frequency of circulating, but not tissue regulatory T cells in patients with endometriosis
Ali-Akbar Delbandi, Mahmoud Mahmoudi, Adel Shervin, Zahra Moradi, Tahereh Arablou, Amir-Hassan Zarnani
Journal of Reproductive Immunology.2020; 139: 103119. CrossRef Preoperative Circulating Lymphocyte and Monocyte Counts Correlate with Patient Outcomes in Type I and Type II Endometrial Cancer
Brian Burgess, Beverly Levine, Robert N. Taylor, Michael G. Kelly
Reproductive Sciences.2020; 27(1): 194. CrossRef Clinicopathologic Features and Prognostic Role of CD3, CD8, and PD-1 positive Tumor-Infiltrating Lymphocytes and the Association with COX-2 Overexpression in Endometrial Carcinoma
Niusha Nobari, Nakisa Niknejad, Jalal Poorolajal, Maryam Vaezi, Fatemeh Nili, Issa Jahanzad
International Journal of Cancer Management.2020;[Epub] CrossRef MMR deficient undifferentiated/dedifferentiated endometrial carcinomas showing significant programmed death ligand-1 expression (sp 142) with potential therapeutic implications
Sean Hacking, Cao Jin, Miglena Komforti, Sharon Liang, Mansoor Nasim
Pathology - Research and Practice.2019; 215(10): 152552. CrossRef The impact of programmed cell death-ligand 1 (PD-L1) and CD8 expression in grade 3 endometrial carcinomas
Stylianos Vagios, Petros Yiannou, Elpida Giannikaki, Triada Doulgeraki, Christos Papadimitriou, Alexandros Rodolakis, Afroditi Nonni, Athanassios Vlachos, Kitty Pavlakis
International Journal of Clinical Oncology.2019; 24(11): 1419. CrossRef Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer
Yuji Ikeda, Kazuma Kiyotani, Poh Yin Yew, Sho Sato, Yuichi Imai, Rui Yamaguchi, Satoru Miyano, Keiichi Fujiwara, Kosei Hasegawa, Yusuke Nakamura
Oncology Reports.2017; 37(5): 2603. CrossRef Hormone therapy as a management strategy for lung metastasis after 5 years of endometrial cancer
Huifang Zhao, Yushuang Yao, Hongjuan Yang, Dehua Ma, Aiping Chen
Medicine.2017; 96(51): e9223. CrossRef Imiquimod Induces Apoptosis in Human Endometrial Cancer Cells In vitro and Prevents Tumor Progression In vivo
Aliyah Almomen, Elke A. Jarboe, Mark K. Dodson, C. Matthew Peterson, Shawn C. Owen, Margit M. Janát-Amsbury
Pharmaceutical Research.2016; 33(9): 2209. CrossRef THE MODELING OF CLINICAL OUTCOMES IN PATIENTS WITH ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA OF THE UTERINE BODY
D. A. Zinovkin, E. A. Nadyrov
Health and Ecology Issues.2016; (4): 114. CrossRef
|